Zaloguj Zarejestruj się zadarmo

Last updated: 23 July 2019 at 5:34pm EST

John A Montgomery Net Worth




The estimated Net Worth of John A Montgomery is at least $671 Tysiąc dollars as of 4 November 2003. John Montgomery owns over 40,000 units of Biocryst Pharmaceuticals stock worth over $670,848 and over the last 21 years John sold BCRX stock worth over $0.

John Montgomery BCRX stock SEC Form 4 insiders trading

John has made over 1 trades of the Biocryst Pharmaceuticals stock since 2003, according to the Form 4 filled with the SEC. Most recently John exercised 40,000 units of BCRX stock worth $240,000 on 4 November 2003.

The largest trade John's ever made was exercising 40,000 units of Biocryst Pharmaceuticals stock on 4 November 2003 worth over $240,000. On average, John trades about 40,000 units every 0 days since 2003. As of 4 November 2003 John still owns at least 86,785 units of Biocryst Pharmaceuticals stock.

You can see the complete history of John Montgomery stock trades at the bottom of the page.



What's John Montgomery's mailing address?

John's mailing address filed with the SEC is 2190 PARKWAY LAKE DR, , BIRMINGHAM, AL, 35244.

Insiders trading at Biocryst Pharmaceuticals

Over the last 24 years, insiders at Biocryst Pharmaceuticals have traded over $76,362,383 worth of Biocryst Pharmaceuticals stock and bought 4,042,003 units worth $20,848,654 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Brothers Life Sciences Capi... oraz Carl L Gordon. On average, Biocryst Pharmaceuticals executives and independent directors trade stock every 31 days with the average trade being worth of $542,329. The most recent stock trade was executed by Amy E Mc Kee on 24 June 2024, trading 8,600 units of BCRX stock currently worth $54,352.



What does Biocryst Pharmaceuticals do?

biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.



What does Biocryst Pharmaceuticals's logo look like?

Biocryst Pharmaceuticals Inc. logo

Complete history of John Montgomery stock trades at Biocryst Pharmaceuticals

Data
#
Firma
 Osoba
Trans.
Transakcja
 Ilość akcji Cena za akcję Łączna cena Ilość akcji po Źródło
4 Nov 2003 BCRX Biocryst Pharmaceuticals Inc. John A Montgomery
Dyrektor
 Opcja Ćwiczenie 40,000 $6.00 $240,000
4 Nov 2003
86,785 ↗


Biocryst Pharmaceuticals executives and stock owners

Biocryst Pharmaceuticals executives and other stock owners filed with the SEC include: